Advanced search
Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 37, 2024 - Issue 3
Submit an article Journal homepage
49
Views
0
CrossRef citations to date
0
Altmetric
Original Research: Gynecology

The effect of polycystic ovarian syndrome on fibrocystic breast changes in postmenopausal women

Brittany Danga John Sealy School of Medicine, The University of Texas Medical Branch, Galveston, Texas, USA
, BA,
Madison Clewisa John Sealy School of Medicine, The University of Texas Medical Branch, Galveston, Texas, USACorrespondence[email protected]
, BS,
Brittany Milesb Department of Radiology, Baylor University Medical Center, Dallas, Texas, USA
, MD &
Quan Nguyenc Department of Radiology, Baylor College of Medicine, Houston, Texas, USA
, MD
Pages 432-436 | Received 16 Apr 2023, Accepted 02 Jan 2024, Published online: 01 Feb 2024

  • Norwood SL. Fibrocystic breast disease an update and review. J Obstet Gynecol Neonatal Nurs. 1990;19(2):116–121. doi:10.1111/j.1552-6909.1990.tb01629.x.
  • Love SM, Gelman RS, Silen W. Fibrocystic disease of the breast—a nondisease? N Engl J Med. 1982;307(16):1010–1014. doi:10.1056/NEJM198210143071611.
  • Stachs A, Stubert J, Reimer T, Hartmann S. Benign breast disease in women. Dtsch Ärztebl Int. 2019;116:565–574. doi:10.3238/arztebl.2019.0565.
  • Cho SH, Park SH. Mimickers of breast malignancy on breast sonography. J Ultrasound Med. 2013;32(11):2029–2036. doi:10.7863/ultra.32.11.2029.
  • Masood S, Rosa M. Borderline breast lesions: diagnostic challenges and clinical implications. Adv Anat Pathol. 2011;18(3):190–198. doi:10.1097/PAP.0b013e31821698cc.
  • Tan-Chiu E, Wang J, Costantino JP, et al. Effects of tamoxifen on benign breast disease in women at high risk for breast cancer. J Natl Cancer Inst. 2003;95(4):302–307. doi:10.1093/jnci/95.4.302.
  • D'Amelio R, Farris M, Grande S, Feraudo E, Iuliano A, Zichella L. Association between polycystic ovary and fibrocystic breast disease. Gynecol Obstet Invest. 2001;51(2):134–137. doi:10.1159/000052909.
  • Gumus II, Koktener A, Dogan D, Turhan NO. OC122: Polycystic ovary syndrome and fibrocystic breast disease: Is there any association? Ultrasound Obstet Gynecol. 2008;32(3):283–283. doi:10.1002/uog.5530.
  • Kohnepoushi P, Dehghanbanadaki H, Mohammadzedeh P, Nikouei M, Moradi Y. The effect of the polycystic ovary syndrome and hypothyroidism on the risk of fibrocystic breast changes: a meta-analysis. Cancer Cell Int. 2022;22(1):125. doi:10.1186/s12935-022-02547-5.
  • Wild S, Pierpoint T, Jacobs H, McKeigue P. Long-term consequences of polycystic ovary syndrome: Results of a 31 year follow-up study. Hum Fertil (Camb). 2000;3(2):101–105. doi:10.1080/1464727002000198781.
  • Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010;8(1):41. doi:10.1186/1741-7015-8-41.
  • Azziz R, Carmina E, Chen Z, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2(1):16057. doi:10.1038/nrdp.2016.57.
  • Margolin E, Zhornitzki T, Kopernik G, Kogan S, Schattner A, Knobler H. Polycystic ovary syndrome in post-menopausal women—marker of the metabolic syndrome. Maturitas. 2005;50(4):331–336. doi:10.1016/j.maturitas.2004.09.005.
  • Krentz AJ, Von Mühlen D, Barrett-Connor E. Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose-effect association with prevalent cardiovascular disease. Menopause. 2007;14(2):284–292. doi:10.1097/GME.0b013e31802cc7ab.
  • Fenton A, Panay N. Management of polycystic ovary syndrome in postmenopausal women: a medical black hole. Climacteric. 2008;11(2):89–90. doi:10.1080/13697130801972304.
  • Winters SJ, Talbott E, Guzick DS, Zborowski J, McHugh KP. Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome. Fertil Steril. 2000;73(4):724–729. doi:10.1016/S0015-0282(99)00641-X.
  • Metcalf MG, Mackenzie JA. Menstrual cycle and exposure to oestrogens unopposed by progesterone: relevance to studies on breast cancer incidence. J Endocrinol. 1985;104(1):137–141. doi:10.1677/joe.0.1040137.
  • Piltonen T, Koivunen R, Perheentupa A, Morin-Papunen L, Ruokonen A, Tapanainen JS. Ovarian age-related responsiveness to human chorionic gonadotropin in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2004;89(8):3769–3775. doi:10.1210/jc.2003-031851.
  • Puurunen J, Piltonen T, Jaakkola P, Ruokonen A, Morin-Papunen L, Tapanainen JS. Adrenal androgen production capacity remains high up to menopause in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2009;94(6):1973–1978. doi:10.1210/jc.2008-2583.
  • Dumitrescu R, Mehedintu C, Briceag I, Purcarea VL, Hudita D. The polycystic ovary syndrome: an update on metabolic and hormonal mechanisms. J Med Life. 2015;8(2):142–145.
  • Schmidt J, Brännström M, Landin-Wilhelmsen K, Dahlgren E. Reproductive hormone levels and anthropometry in postmenopausal women with polycystic ovary syndrome (PCOS): a 21-year follow-up study of women diagnosed with PCOS around 50 years ago and their age-matched controls. J Clin Endocrinol Metab. 2011;96(7):2178–2185. doi:10.1210/jc.2010-2959.
  • Dietzel M, Kaiser CG, Wenkel E, et al. Differentiation of ductal carcinoma in situ versus fibrocystic changes by magnetic resonance imaging: are there pathognomonic imaging features? Acta Radiol. 2017;58(10):1206–1214. doi:10.1177/0284185117690420.
  • Chen J, Nalcioglu O, Su M. Fibrocystic change of the breast presenting as a focal lesion mimicking breast cancer in MR imaging. J Magn Reson Imaging. 2008;28(6):1499–1505. doi:10.1002/jmri.21455.
  • Cho MW, Grimm LJ, Johnson KS. Focal breast pain. Acad Radiol. 2017;24(1):53–59. doi:10.1016/j.acra.2016.09.004.
  • Yao JP, Hao YZ, Chang Q, et al. Value of ultrasonographic features for assessing malignant potential of complex cystic breast lesions. J Ultrasound Med. 2017;36(4):699–704. doi:10.7863/ultra.16.05012.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.